Preview
Bloomberg reports that Hangzhou-based BrainCo is developing a wearable device that it says could suppress appetite by stimulating the brain, positioned as a non-drug alternative to GLP-1 treatments such as Wegovy and Zepbound. A founding partner described…
The complete summary, “why it matters” analysis and the original source link are available to members.
NeuromodulationBCI